1. George, F. W., and Wilson, J. D. (1994) Sex determination and Differentiation. In The Physiology of Reproduction. Chapter 1. (Knobil, E., and Neill, J. D., eds), Raven Press Ltd, New York

2. Wilson, J. D., Griffin, J. E., and Russell, D. W. (1993) Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 14, 577-593.

3. Randall, V. A. (1994) Role of 5 alpha-reductase in health and disease. Baillieres Clin Endocrinol Metab 8, 405-431.

4. Grino, P. B., Griffin, J. E., and Wilson, J. D. (1990) Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 126, 1165-1172

5. El-Gehani, F., Zhang, F. P., Pakarinen, P., Rannikko, A., and Huhtaniemi, I. (1998) Gonadotropin-independent regulation of steroidogenesis in the fetal rat testis. Biol Reprod 58, 116-123.

6. Brinkmann, A. O., and van Straalen, R. J. (1979) Development of the LH-response in fetal guinea pig testes. Biol Reprod 21, 991-997.

7. O'Shaughnessy, P. J., Baker, P., Sohnius, U., Haavisto, A. M., Charlton, H. M., and Huhtaniemi, I. (1998) Fetal development of Leydig cell activity in the mouse is independent of pituitary gonadotroph function. Endocrinology 139, 1141-1146.

8. Curtin, D., Jenkins, S., Farmer, N., Anderson, A. C., Haisenleder, D. J., Rissman, E., Wilson, E. M., and Shupnik, M. A. (2001) Androgen suppression of GnRH-stimulated rat LHbeta gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region. Mol Endocrinol 15, 1906-1917.

9. Stocco, D. M., and Clark, B. J. (1996) Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 17, 221-244.

10. Miller, W. L. (1988) Molecular biology of steroid hormone synthesis. Endocr Rev 9, 295-318.

11. Russell, D. W., and Wilson, J. D. (1994) Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem 63, 25-61.

12. Andersson, S., Berman, D. M., Jenkins, E. P., and Russell, D. W. (1991) Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354, 159-161.

13. Andersson, S., Bishop, R. W., and Russell, D. W. (1989) Expression cloning and regulation of steroid 5 alpha-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 264, 16249-16255.

14. Mahendroo, M. S., Cala, K. M., and Russell, D. W. (1996) 5 alpha-reduced androgens play a key role in murine parturition. Mol Endocrinol 10, 380-392.

15. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.

16. Laudet, V., Hanni, C., Coll, J., Catzeflis, F., and Stehelin, D. (1992) Evolution of the nuclear receptor gene superfamily. Embo J 11, 1003-1013.

17. Robinson-Rechavi, M., Carpentier, A. S., Duffraisse, M., and Laudet, V. (2001) How many nuclear hormone receptors are there in the human genome? Trends Genet 17, 554-556.

18. Enmark, E., and Gustafsson, J. A. (1996) Orphan nuclear receptors--the first eight years. Mol Endocrinol 10, 1293-1307.

19. Migliaccio, A., Castoria, G., Di Domenico, M., de Falco, A., Bilancio, A., Lombardi, M., Barone, M. V., Ametrano, D., Zannini, M. S., Abbondanza, C., and Auricchio, F. (2000) Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. Embo J 19, 5406-5417.

20. Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., Roberson, P. K., Weinstein, R. S., Jilka, R. L., and Manolagas, S. C. (2001) Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719-730.

21. Lutz, L. B., Cole, L. M., Gupta, M. K., Kwist, K. W., Auchus, R. J., and Hammes, S. R. (2001) Evidence that androgens are the primary steroids produced by Xenopus laevis ovaries and may signal through the classical androgen receptor to promote oocyte maturation. Proc Natl Acad Sci U S A 98, 13728-13733.

22. Chang, C. S., Kokontis, J., and Liao, S. T. (1988) Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240, 324-326

23. Lubahn, D. B., Joseph, D. R., Sullivan, P. M., Willard, H. F., French, F. S., and Wilson, E. M. (1988) Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240, 327-330

24. Trapman, J., Klaassen, P., Kuiper, G. G., van der Korput, J. A., Faber, P. W., van Rooij, H. C., Geurts van Kessel, A., Voorhorst, M. M., Mulder, E., and Brinkmann, A. O. (1988) Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 153, 241-248

25. Tilley, W. D., Marcelli, M., Wilson, J. D., and McPhaul, M. J. (1989) Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci U S A 86, 327-331

26. Brown, C. J., Goss, S. J., Lubahn, D. B., Joseph, D. R., Wilson, E. M., French, F. S., and Willard, H. F. (1989) Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet 44, 264-269

27. van Laar, J. H., Bolt-de Vries, J., Voorhorst-Ogink, M. M., and Brinkmann, A. O. (1989) The human androgen receptor is a 110 kDa protein. Mol Cell Endocrinol 63, 39-44

28. Kuiper, G. G., Faber, P. W., van Rooij, H. C., van der Korput, J. A., Ris-Stalpers, C., Klaassen, P., Trapman, J., and Brinkmann, A. O. (1989) Structural organization of the human androgen receptor gene. J Mol Endocrinol 2, R1-4

29. Lubahn, D. B., Brown, T. R., Simental, J. A., Higgs, H. N., Migeon, C. J., Wilson, E. M., and French, F. S. (1989) Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity [published erratum appears in Proc Natl Acad Sci U S A 1990 Jun;87(11):4411]. Proc Natl Acad Sci U S A 86, 9534-9538

30. Faber, P. W., van Rooij, H. C., van der Korput, H. A., Baarends, W. M., Brinkmann, A. O., Grootegoed, J. A., and Trapman, J. (1991) Characterization of the human androgen receptor transcription unit. J Biol Chem 266, 10743-10749

31. Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Thompson, E. B., Rosenfeld, M. G., and Evans, R. M. (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318, 635-641.

32. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., and Chambon, P. (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320, 134-139.

33. Misrahi, M., Atger, M., d'Auriol, L., Loosfelt, H., Meriel, C., Fridlansky, F., Guiochon-Mantel, A., Galibert, F., and Milgrom, E. (1987) Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun 143, 740-748.

34. Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., and Evans, R. M. (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237, 268-275.

35. Faber, P. W., Kuiper, G. G., van Rooij, H. C., van der Korput, J. A., Brinkmann, A. O., and Trapman, J. (1989) The N-terminal domain of the human androgen receptor is encoded by one, large exon. Mol Cell Endocrinol 61, 257-262.

36. Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J. A. (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 93, 5925-5930.

37. Sleddens, H. F., Oostra, B. A., Brinkmann, A. O., and Trapman, J. (1992) Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res 20, 1427.

38. Boehmer, A. L., Brinkmann, A. O., Niermeijer, M. F., Bakker, L., Halley, D. J., and Drop, S. L. (1997) Germ-line and somatic mosaicism in the androgen insensitivity syndrome: implications for genetic counseling. Am J Hum Genet 60, 1003-1006.

39. Li, S. L., Ting, S. S., Lindeman, R., Ffrench, R., and Ziegler, J. B. (1998) Carrier identification in X-linked immunodeficiency diseases. J Paediatr Child Health 34, 273-279.

40. Nance, M. A. (1997) Clinical aspects of CAG repeat diseases. Brain Pathol 7, 881-900.

41. Jenster, G., de Ruiter, P. E., van der Korput, H. A., Kuiper, G. G., Trapman, J., and Brinkmann, A. O. (1994) Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33, 14064-14072.

42. Kazemi-Esfarjani, P., Trifiro, M. A., and Pinsky, L. (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4, 523-527.

43. Hardy, D. O., Scher, H. I., Bogenreider, T., Sabbatini, P., Zhang, Z. F., Nanus, D. M., and Catterall, J. F. (1996) Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 81, 4400-4405.

44. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Dahl, D., Brufsky, A., Talcott, J., Hennekens, C. H., and Kantoff, P. W. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A 94, 3320-3323.

45. Cude, K. J., Montgomery, J. S., Price, D. K., Dixon, S. C., Kincaid, R. L., Kovacs, K. F., Venzon, D. J., Liewehr, D. J., Johnson, M. E., Reed, E., and Figg, W. D. (2002) The role of an androgen receptor polymorphism in the clinical outcome of patients with metastatic prostate cancer. Urol Int 68, 16-23.

46. Correa-Cerro, L., Wohr, G., Haussler, J., Berthon, P., Drelon, E., Mangin, P., Fournier, G., Cussenot, O., Kraus, P., Just, W., Paiss, T., Cantu, J. M., and Vogel, W. (1999) (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 7, 357-362.

47. Freedman, M. L., Pearce, C. L., Penney, K. L., Hirschhorn, J. N., Kolonel, L. N., Henderson, B. E., and Altshuler D. (2005) Systematic evaluation of genetic variation at the Androgen receptor locus and risk of prostate cancer in a multiethnic cohort study. Am J Hum Genet 76, 82 ¿ 90.

48. Dowsing, A. T., Yong, E. L., Clark, M., McLachlan, R. I., de Kretser, D. M., and Trounson, A. O. (1999) Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 354, 640-643.

49. Mifsud, A., Sim, C. K., Boettger-Tong, H., Moreira, S., Lamb, D. J., Lipshultz, L. I., and Yong, E. L. (2001) Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. Fertil Steril 75, 275-281.

50. Wallerand, H., Remy-Martin, A., Chabannes, E., Bermont, L., Adessi, G. L., and Bittard, H. (2001) Relationship between expansion of the CAG repeat in exon 1 of the androgen receptor gene and idiopathic male infertility. Fertil Steril 76, 769-774.

51. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E., and Fischbeck, K. H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79.

52. Kennedy, W. R., Alter, M., and Sung, J. H. (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18, 671-680.

53. Robitaille, Y., Lopes-Cendes, I., Becher, M., Rouleau, G., and Clark, A. W. (1997) The neuropathology of CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol 7, 901-926.

54. Jenster, G., van der Korput, H. A., Trapman, J., and Brinkmann, A. O. (1995) Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 270, 7341-7346.

55. Langley, E., Zhou, Z. X., and Wilson, E. M. (1995) Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270, 29983-29990.

56. Doesburg, P., Kuil, C. W., Berrevoets, C. A., Steketee, K., Faber, P. W., Mulder, E., Brinkmann, A. O., and Trapman, J. (1997) Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry 36, 1052-1064.

57. Berrevoets, C. A., Doesburg, P., Steketee, K., Trapman, J., and Brinkmann, A. O. (1998) Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol Endocrinol 12, 1172-1183.

58. Zhou, Z. X., Lane, M. V., Kemppainen, J. A., French, F. S., and Wilson, E. M. (1995) Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 9, 208-218.

59. Thompson, J., Saatcioglu, F., Janne, O. A., and Palvimo, J. J. (2001) Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol Endocrinol 15, 923-935.

60. Luisi, B. F., Xu, W. X., Otwinowski, Z., Freedman, L. P., Yamamoto, K. R., and Sigler, P. B. (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505.

61. Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., and Gewirth, D. T. (2004) Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A 101, 4758-4763.

62. Fu, M., Wang, C., Zhang, X., and Pestell, R. G. (2004) Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem Pharmacol 68, 1199 ¿ 1208.

63. Brinkmann, A. O., and Trapman, J. (2000) Genetic analysis of androgen receptors in development and disease. Adv Pharmacol 47, 317-341

64. Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., Basler, S., Schafer, M., Egner, U., and Carrondo, M. A. (2000) Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275, 26164-26171.

65. Sack, J. S., Kish, K. F., Wang, C., Attar, R. M., Kiefer, S. E., An, Y., Wu, G. Y., Scheffler, J. E., Salvati, M. E., Krystek, S. R., Jr., Weinmann, R., and Einspahr, H. M. (2001) Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci U S A 98, 4904-4909.

66. Jenster, G., van der Korput, H. A., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., and Brinkmann, A. O. (1991) Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 5, 1396-1404.

67. Hollenberg, S. M., and Evans, R. M. (1988) Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55, 899-906.

68. Kuiper, G. G., de Ruiter, P. E., Grootegoed, J. A., and Brinkmann, A. O. (1991) Synthesis and post-translational modification of the androgen receptor in LNCaP cells. Mol Cell Endocrinol 80, 65-73.

69. Zhou, Z. X., Kemppainen, J. A., and Wilson, E. M. (1995) Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol 9, 605-615.

70. Blok, L. J., de Ruiter, P. E., and Brinkmann, A. O. (1998) Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry 37, 3850-3857.

71. Wong, H. Y., Burghoorn, J. A., Van Leeuwen, M., De Ruiter, P. E., Scippers, E., Blok, L. J., Li, K. W., Dekker, H. I., De Jong, L., Trapman, J., Grootegoed, J. A., and Brinkmann, A. O. (2004) Phosphorylation of Androgen Receptor isoforms. Biochem J 383, 267 ¿ 276.

72. Kuiper, G. G., de Ruiter, P. E., Trapman, J., Jenster, G., and Brinkmann, A. O. (1993) In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein. Biochem J 296, 161-167.

73. Brüggenwirth, H. T., Boehmer, A. L., Ramnarain, S., Verleun-Mooijman, M. C., Satijn, D. P., Trapman, J., Grootegoed, J. A., and Brinkmann, A. O. (1997) Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation. Am J Hum Genet 61, 1067-1077.

74. Craft, N., Shostak, Y., Carey, M., and Sawyers, C. L. (1999) A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase [see comments]. Nat Med 5, 280-285

75. Yeh, S., Lin, H. K., Kang, H. Y., Thin, T. H., Lin, M. F., and Chang, C. (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci U S A 96, 5458-5463

76. Neumann, F., and Topert, M. (1986) Pharmacology of antiandrogens. J Steroid Biochem 25, 885-895.

77. Raynaud, J. P., and Ojasoo, T. (1986) The design and use of sex-steroid antagonists. J Steroid Biochem 25, 811-833

78. Furr, B. J., Valcaccia, B., Curry, B., Woodburn, J. R., Chesterson, G., and Tucker, H. (1987) ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen. J Endocrinol 113, R7-9

79. Kuil, C. W., and Mulder, E. (1994) Mechanism of antiandrogen action: conformational changes of the receptor. Mol Cell Endocrinol 102, R1-5.

80. Kuil, C. W., Berrevoets, C. A., and Mulder, E. (1995) Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. Studies on the mechanism of antiandrogen action. J Biol Chem 270, 27569-27576.

81. Negro-Vilar, A. (1999) Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium [In Process Citation]. J Clin Endocrinol Metab 84, 3459-3462

82. Berrevoets, C. A., Umar, A., Trapman, J., and Brinkmann, A. O. (2004) Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR). Biochem J 379, 731 ¿ 738.

83. Reifenstein, E. C. (1947) Hereditary female hypogonadism. Proc Am Fed Clin Res 3, 86.

84. Wilson, J. D., Harrod, M. J., Goldstein, J. L., Hemsell, D. L., and MacDonald, P. C. (1974) Familial incomplete male pseudohermaphroditism, type 1. Evidence for androgen resistance and variable clinical manifestations in a family with the Reifenstein syndrome. N Engl J Med 290, 1097-1103.

85. Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., and Andersson, S. (1994) Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3. Nat Genet 7, 34-39.

86. Sai, T. J., Seino, S., Chang, C. S., Trifiro, M., Pinsky, L., Mhatre, A., Kaufman, M., Lambert, B., Trapman, J., Brinkmann, A. O., and et al. (1990) An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity. Am J Hum Genet 46, 1095-1100

87. Quigley, C. A., De Bellis, A., Marschke, K. B., el-Awady, M. K., Wilson, E. M., and French, F. S. (1995) Androgen receptor defects: historical, clinical, and molecular perspectives [published erratum appears in Endocr Rev 1995 Aug;16(4):546]. Endocr Rev 16, 271-321

88. Boehmer, A. L., Brinkmann, A. O., Nijman, R. M., Verleun-Mooijman, M. C., de Ruiter, P., Niermeijer, M. F., and Drop, S. L. (2001) Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. J Clin Endocrinol Metab 86, 1240-1246.

89. Batch, J. A., Davies, H. R., Evans, B. A., Hughes, I. A., and Patterson, M. N. (1993) Phenotypic variation and detection of carrier status in the partial androgen insensitivity syndrome. Arch Dis Child 68, 453-457

90. Imasaki, K., Hasegawa, T., Okabe, T., Sakai, Y., Haji, M., Takayanagi, R., and Nawata, H. (1994) Single amino acid substitution (840Arg-->His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor. Eur J Endocrinol 130, 569-574

91. Evans, B. A., Hughes, I. A., Bevan, C. L., Patterson, M. N., and Gregory, J. W. (1997) Phenotypic diversity in siblings with partial androgen insensitivity syndrome. Arch Dis Child 76, 529-531

92. Boehmer, A. L., Brinkmann, A. O., Brüggenwirth, H., van Assendelft, C., Otten, B. J., Verleun-Mooijman, M. C., Niermeijer, M. F., Brunner, H. G., Rouwe, C. W., Waelkens, J. J., Oostdijk, W., Kleijer, W. J., van der Kwast, T. H., de Vroede, M. A., and Drop, S. L. (2001) Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86, 4151-4160.

93. Lu, J., and Danielsen, M. (1996) A Stu I polymorphism in the human androgen receptor gene (AR). Clin Genet 49, 323-324.

94. Ris-Stalpers, C., Hoogenboezem, T., Sleddens, H. F., Verleun-Mooijman, M. C., Degenhart, H. J., Drop, S. L., Halley, D. J., Oosterwijk, J. C., Hodgins, M. B., Trapman, J., and et al. (1994) A practical approach to the detection of androgen receptor gene mutations and pedigree analysis in families with x-linked androgen insensitivity. Pediatr Res 36, 227-234

95. Davies, H. R., Hughes, I. A., and Patterson, M. N. (1995) Genetic counselling in complete androgen insensitivity syndrome: trinucleotide repeat polymorphisms, single-strand conformation polymorphism and direct detection of two novel mutations in the androgen receptor gene. Clin Endocrinol (Oxf) 43, 69-77

96. Gottlieb, B., Beitel, L. K., Wu, J. H., and Trifiro, M. A. (2004) The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23, 527-533.

97. Kohler, B., Lumbroso, S., Leger, J., Audran, F., Grau, E. S., Kurtz, F., Pinto, G., Salerno, M., Semitcheva, T., Czernichov, P., and Sultan, C. (2005) Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counselling. J Clin Endocrinol Metab 90, 106 - 111

98. Choong, C. S., Quigley, C. A., French, F. S., and Wilson, E. M. (1996) A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation. J Clin Invest 98, 1423-1431

99. McPhaul, M. J., Marcelli, M., Tilley, W. D., Griffin, J. E., Isidro-Gutierrez, R. F., and Wilson, J. D. (1991) Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest 87, 1413-1421

100. Lobaccaro, J. M., Poujol, N., Chiche, L., Lumbroso, S., Brown, T. R., and Sultan, C. (1996) Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations. Mol Cell Endocrinol 116, 137-147

101. Brüggenwirth, H. T., Boehmer, A. L., Lobaccaro, J. M., Chiche, L., Sultan, C., Trapman, J., and Brinkmann, A. O. (1998) Substitution of Ala564 in the first zinc cluster of the deoxyribonucleic acid (DNA)-binding domain of the androgen receptor by Asp, Asn, or Leu exerts differential effects on DNA binding. Endocrinology 139, 103-110.

102. Nguyen, D., Steinberg, S. V., Rouault, E., Chagnon, S., Gottlieb, B., Pinsky, L., Trifiro, M., and Mader, S. (2001) A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome. Mol Endocrinol 15, 1790-1802.

103. Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A., and Stratton, M. R. (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2, 132-134

104. Lobaccaro, J. M., Lumbroso, S., Belon, C., Galtier-Dereure, F., Bringer, J., Lesimple, T., Heron, J. F., Pujol, H., and Sultan, C. (1993) Male breast cancer and the androgen receptor gene [letter]. Nat Genet 5, 109-110

105. Gast, A., Neuschmid-Kaspar, F., Klocker, H., and Cato, A. C. (1995) A single amino acid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome. Mol Cell Endocrinol 111, 93-98

106. Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schutz, G. (1998) DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531-541.

107. Giwercman, Y. L., Ivarsson, S. A., Richthoff, J., Lundin, K. B., and Giwercman, A. (2004) A novel mutation in the D-box of the androgen receptor gene (S579R) in two unrelated individuals is associated with both normal phenotype and severe PAIS. Horm Res 61, 58 - 62

108. Pinsky, L., Trifiro, M., Kaufman, M., Beitel, L. K., Mhatre, A., Kazemi-Esfarjani, P., Sabbaghian, N., Lumbroso, R., Alvarado, C., and Vasiliou, M. (1992) Androgen resistance due to mutation of the androgen receptor. Clin Invest Med 15, 456-472

109. Hiort, O., Sinnecker, G. H., Holterhus, P. M., Nitsche, E. M., and Kruse, K. (1998) Inherited and de novo androgen receptor gene mutations: investigation of single-case families [see comments]. J Pediatr 132, 939-943

110. Lundberg Giwercman, Y., Nikoshkov, A., Lindsten, K., Bystrom, B., Pousette, A., Chibalin, A. V., Arvidsson, S., Tiulpakov, A., Semitcheva, T. V., Peterkova, V., Hagenfeldt, K., Ritzen, E. M., and Wedell, A. (1998) Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome. Hum Genet 103, 529-531.

111. Umar, A., Berrevoets, C. A., Van, N. M., Van Leeuwen, M., Verbiest, M., Kleijer, W. J., Dooijes, D., Grootegoed, J. A., Drop. S. L., and Brinkmann, A. O. (2005) Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity. J Clin Endocrinol Metab 90, 507- 515.

112. Brown, T. R., Lubahn, D. B., Wilson, E. M., Joseph, D. R., French, F. S., and Migeon, C. J. (1988) Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. Proc Natl Acad Sci U S A 85, 8151-8155

113. Akin, J. W., Behzadian, A., Tho, S. P., and McDonough, P. G. (1991) Evidence for a partial deletion in the androgen receptor gene in a phenotypic male with azoospermia. Am J Obstet Gynecol 165, 1891-1894.

114. Trifiro, M., Gottlieb, B., Pinsky, L., Kaufman, M., Prior, L., Belsham, D. D., Wrogemann, K., Brown, C. J., Willard, H. F., Trapman, J., and et al. (1991) The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor gene. Mol Cell Endocrinol 75, 37-47.

115. Quigley, C. A., Evans, B. A., Simental, J. A., Marschke, K. B., Sar, M., Lubahn, D. B., Davies, P., Hughes, I. A., Wilson, E. M., and French, F. S. (1992) Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo. Mol Endocrinol 6, 1103-1112.

116. MacLean, H. E., Chu, S., Warne, G. L., and Zajac, J. D. (1993) Related individuals with different androgen receptor gene deletions. J Clin Invest 91, 1123-1128

117. Ris-Stalpers, C., Verleun-Mooijman, M. C., de Blaeij, T. J., Degenhart, H. J., Trapman, J., and Brinkmann, A. O. (1994) Differential splicing of human androgen receptor pre-mRNA in X-linked Reifenstein syndrome, because of a deletion involving a putative branch site [published erratum appears in Am J Hum Genet 1994 Aug;55(2):419]. Am J Hum Genet 54, 609-617

118. Jakubiczka, S., Nedel, S., Werder, E. A., Schleiermacher, E., Theile, U., Wolff, G., and Wieacker, P. (1997) Mutations of the androgen receptor gene in patients with complete androgen insensitivity. Hum Mutat 9, 57-61

119. Ris-Stalpers, C., Kuiper, G. G., Faber, P. W., Schweikert, H. U., van Rooij, H. C., Zegers, N. D., Hodgins, M. B., Degenhart, H. J., Trapman, J., and Brinkmann, A. O. (1990) Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc Natl Acad Sci U S A 87, 7866-7870

120. Evans, B. A. J., Ismail, R. A., France, T., and Hughes, I. A. (1991) Analysis of the androgen receptor gene structure in a patient with complete androgen insensitivity syndrome. J. Endocrinology 129, Abstr 65

121. Yong, E. L., Chua, K. L., Yang, M., Roy, A., and Ratnam, S. (1994) Complete androgen insensitivity due to a splice-site mutation in the androgen receptor gene and genetic screening with single-stranded conformation polymorphism. Fertil Steril 61, 856-862

122. Avila, D. M., Wilson, C. M., Nandi, N., Griffin, J. E., and McPhaul, M.J. (2002) Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays. J Clin Endocrinol Metab 87, 182-188.

123. Trifiro, M. A., Lumbroso, R., Beitel, L. K., Vasiliou, D. M., Bouchard, J., Deal, C., Van Vliet, G., and Pinsky, L. (1997) Altered mRNA expression due to insertion or substitution of thymine at position +3 of two splice-donor sites in the androgen receptor gene. Eur J Hum Genet 5, 50-58

124. Zhu, Y. S., Katz, M. D., and Imperato-McGinley, J. (1998) Natural potent androgens: lessons from human genetic models. Baillieres Clin Endocrinol Metab 12, 83-113.

125. Sinnecker, G. H., Hiort, O., Dibbelt, L., Albers, N., Dorr, H. G., Hauss, H., Heinrich, U., Hemminghaus, M., Hoepffner, W., Holder, M., Schnabel, D., and Kruse, K. (1996) Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. Am J Med Genet 63, 223-230.

126. Forti, G., Falchetti, A., Santoro, S., Davis, D. L., Wilson, J. D., and Russell, D. W. (1996) Steroid 5 alpha-reductase 2 deficiency: virilization in early infancy may be due to partial function of mutant enzyme. Clin Endocrinol (Oxf) 44, 477-482.

127. Canto, P., Vilchis, F., Chavez, B., Mutchinick, O., Imperato-McGinley, J., Perez-Palacios, G., Ulloa-Aguirre, A., and Mendez, J. P. (1997) Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency. Clin Endocrinol (Oxf) 46, 155-160.

128. Hiort, O., Sinnecker, G. H., Willenbring, H., Lehners, A., Zollner, A., and Struve, D. (1996) Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency. J Clin Endocrinol Metab 81, 3415-3418.

129. Boudon, C., Lobaccaro, J. M., Lumbroso, S., Ogur, G., Ocal, G., Belon, C., and Sultan, C. (1995) A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5 alpha-reductase deficiency. Clin Endocrinol (Oxf) 43, 183-188.

130. Vilchis, F., Mendez, J. P., Canto, P., Lieberman, E., and Chavez, B. (2000) Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin Endocrinol (Oxf) 52, 383-387.

131. Silver, R. I., and Russell, D. W. (1999) 5alpha-reductase type 2 mutations are present in some boys with isolated hypospadias. J Urol 162, 1142-1145.

132. Anwar, R., Gilbey, S. G., New, J. P., and Markham, A. F. (1997) Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2). Mol Pathol 50, 51-52.

133. Makridakis, N., Ross, K. K., Pike, M. C., Chang, L., Stanczyk, F. Z., Kolonel, L. N., Shi, C. Y., Yu, M. C., Henderson, B. E., and Reichardt, J. K. (1997) A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase. Cancer Res 57, 1020-1022.

134. Mazen, I., Gad, Y. Z., Hafez, M., Sultan C., and Lumbroso, S. (2003) Molecular analysis of 5¿-reductase type 2 gene in eight unrelated Egyptian children with suspected 5¿-reductase deficiency: prevalence of the G34R mutation. Clin Endocrinol (Oxf) 58, 627-631.

135. Sasaki, G., Nakagawa, K., Hashiguchi, A., Hasegawa, T., Ogata, T., and Murai, M. (2003) Giant seminoma in a patient with 5¿-reductase type 2 deficiency. J Urol 169, 1080-1081.

136. Hiort, O., Schütt, S. M., Bals-Pratsch, M., Holterhus, P-M., Marschke, C., and Struve, D. (2002) A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5¿-reductase deficiency. Int J Androl 25, 55-58.

137. Hafez, M., Mazen, I., Ghali, I., Sultan, C., and Lumbroso, S. (2003) A new mutation of 5-alpha reductase type 2 (A62E) in a large Egyptian kindred. Horm Res 59, 281 ¿ 284.

138. Bahceci, M., Ersay, A. R., Tucu, A., Hiort, O., Richter-Unruh, A., and Gokalp, D., (2005) A novel mutation of 5-alpha-reductase type 2 gene (SDR5A2) leads to severe male pseudohermaphroditism in a Turkish family. Urology 66, 407 ¿ 410.

139. Makridakis, N., Akalu, A., and Reichardt, J. (2004) Identification and characterization of somatic steroid 5¿-reductase (SDR5A2) mutations in human prostate cancer tissue. Oncogene 23, 7399 ¿ 7405.